InsidersTradesSigma
Discover the detailed record of transactions filed by Guido Oelkers, 董事长兼首席执行官. Director active across 2 companies, notably Swedish Orphan Biovitrum AB (publ). Cumulatively, 3 filings have been logged. History available since 27 October 2025. The latest transaction was filed on 31 October 2025 (Purchase). Regulator: FIN-FSA. All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 条申报中的 3 条
Guido Oelkers is the CEO of Swedish Orphan Biovitrum AB (publ). He is responsible for managing the company's operations, which specializes in orphan drugs. His role is essential for achieving the company's strategic objectives.